Abstract
Long COVID is characterized by one or more symptoms experienced by individuals prior to a COVID-19 infection that last for ≥2 months, and its risk factors remain unclear. This study aimed to identify risk factors associated with long COVID among patients admitted between June 1, 2020, and October 31, 2023, at three referral COVID-19 hospitals in Palembang City, Indonesia. This cohort study included adults who were admitted for ≥5 days. The participant’s medical records were reviewed for admission and discharge dates, sociodemographic and clinical characteristics, and vaccination and therapy status. A standardized and validated instrument was used to assess fatigue during admission, and a structured questionnaire was used to evaluate long COVID. Cox regression was employed to determine factors associated with long COVID. Among 256 patients, long COVID was identified in 39.1%. Fatigue during admission, chronic kidney disease, thrombocytosis, and positive RT-PCR test at hospital discharge increased the risk of long COVID, whereas being fully vaccinated decreased its risk. This study identifies five risk factors for long COVID and determines that fatigue during admission is the strongest.
References
1. World Health Organization. A clinical case definition of post COVID-19 condition by a Delphi consensus. Geneva: WHO; 2021.
2. Seighali N, Abdollahi A, Shafiee A, et al. The global prevalence of depression, anxiety, and sleep disorder among patients coping with Post COVID-19 syndrome (long COVID): A systematic review and meta-analysis. BMC Psychiatry. 2024; 24 (1): 105. DOI: 10.1186/s12888-023-05481-6.
3. Qin S, Zhang Y, Li Y, et al. Long COVID fact and findings: A large-scale online survey in 74,075 Chinese participants. Lancet Reg Health West Pac. 2024; 52: 101218. DOI: 10. 1016/j.lanwpc.2024. 101218.
4. Menteri Kesehatan Republik Indonesia. Peraturan Menteri Kesehatan Nomor 23 Tahun 2023 tentang Pedoman Penanggulangan Corono Virus Disease 2019 (COVID-19). Jakarta: Kementerian Kesehatan Republik Indonesia; 2023.
5. Susanto AD, Isbaniah F, Pratomo I, et al. Clinical characteristics and quality of life of persistent symptoms of COVID-19 syndrome in Indonesia. Germs. 2022; 12 (2): 158-168. DOI: 10.18683/germs.2022.1319.
6. Rumah Sakit Mohammad Hoesin. Profil Rumah Sakit Mohammad Hoesin Palembang 2025. Palembang: Rumah Sakit Mohammad Hoesin; 2025.
7. Salim NA, Stevanny B, Putri AA, et al. Post-COVID-19 Syndrome in Healthcare Personnel in Dr. Mohammad Hoesin General Hospital Palembang Indonesia. Int J Infect Dis. 2022; 116: S33. DOI: 10.1016/j.ijid.2021.12.078.
8. Kementerian Kesehatan Republik Indonesia. Dashboard situasi COVID-19. Jakarta: Kementerian Kesehatan Republik Indonesia; 2025.
9. Naik H, Shao S, Tran KC, et al. Evaluating fatigue in patients recovering from COVID-19: Validation of the fatigue severity scale and single item screening questions. Health Qual Life Outcomes. 2022; 20 (1): 170. DOI: 10.1186/s12955-022-02082-x.
10. Ekaputri M, Fadhli R, Faslina M, et al. Hubungan Kelelahan Kerja dengan Tingkat Stres Perawat pada Masa Pandemi di Ruangan Isolasi COVID-19. Malahayati Nurs J. 2022; 4 (6): 1589-1599. DOI: 10.33024/mnj.v4i6.6458.
11. Zhang D, Chen C, Xie Y, et al. Prevalence and risk factors of long COVID-19 persisting for 2 years in Hainan Province: A population-based prospective study. Sci Rep. 2025; 15: 369. DOI: 10.1038/s41598-024-84598-4.
12. Hejazian SS, Sadr AV, Shahjouei S, et al. Prevalence and Determinants of Long-Term Post-COVID Conditions in the United States: 2022 Behavioral Risk Factor Surveillance System. Am J Med. 2024; 138 (3): 513-523.e10. DOI: 10.1016/j.amjmed.2024.02.010.
13. Namie H, Takazono T, Kawasaki R, et al. Analysis of risk factors for long COVID after mild COVID-19 during the Omicron wave in Japan. Respir Investig. 2025; 63 (3): 303-310. DOI: 10.1016/j.resinv.2025.02.008.
14. Pazukhina E, Garcia-Gallo E, Reyes LF, et al. Long COVID: A global health issue - a prospective, cohort study set in four continents. BMJ Glob Health. 2024; 9 (10): e015245. DOI: 10.1136/bmjgh-2024-015245.
15. Wostyn P. COVID-19 and chronic fatigue syndrome: Is the worst yet to come? Med Hypotheses. 2021; 146: 110469. DOI: 10.1016/j.mehy.2020.110469.
16. Selvakumar J, Havdal LB, Brodwall EM, et al. Risk factors for fatigue severity in the post-COVID-19 condition: A prospective controlled cohort study of nonhospitalised adolescents and young adults. Brain Behav Immun Health. 2025; 44: 100967. DOI: 10.1016/j.bbih.2025.100967.
17. Fernandez-de-las-Peñas C, Notarte KI, Macasaet R, et al. Persistence of post-COVID symptoms in the general population two years after SARS-CoV-2 infection: A systematic review and meta-analysis. J Infect. 2024; 88 (2): 77–88. DOI: 10.1016/j.jinf.2023.12.004.
18. Sigfrid L, Drake TM, Pauley E, et al. Long COVID in adults discharged from UK hospitals after COVID-19: A prospective, multicentre cohort study using the ISARIC WHO Clinical Characterisation Protocol. The Lancet Reg Health. 2021; 8: 100186. DOI: 10.1016/j.lanepe.2021.100186.
19. Ceban F, Ling S, Lui LMW, et al. Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta-analysis. Brain Behav Immun. 2022; 101: 93-135. DOI: 10.1016/j.bbi.2021.12.020.
20. Hunt J, Blease C, Geraghty KJ, et al. Long COVID at the crossroads: Comparisons and lessons from the treatment of patients with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). J Health Psychol. 2022; 27 (14): 3106-3120. DOI: 10.1177/13591053221084494.
21. Nalbandian A, Sehgal K, Gupta A, et al. Post-acute COVID-19 syndrome. Nat Med. 2021; 27 (4): 601-615. DOI: 10.1038/s41591-021-01283-z.
22. Tackey C, Slepian PM, Clarke H, et al. Post-Viral Pain, Fatigue, and Sleep Disturbance Syndromes: Current Knowledge and Future Directions. Can J Pain. 2024; 7 (2): 2272999. DOI: 10.1080/24740527.2023.2272999.
23. Cheng Y, Luo R, Wang K, et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 2020; 97 (5): 829838. DOI: 10.1016/j.kint.2020.03.005.
24. Henry BM, Lippi G. Chronic kidney disease is associated with severe coronavirus disease 2019 (COVID-19) infection. Int Urol Nephrol. 2020; 52 (6): 1193-1194. DOI: 10.1007/s11255-020-02451-9.
25. Lopez-Leon S, Wegman-Ostrosky T, Perelman C, et al. More than 50 long-term effects of COVID-19: A systematic review and meta-analysis. Sci Rep. 2021; 11: 16144. DOI: 10.1038/s41598-021-95565-8.
26. Varga Z, Flammer AJ, Steiger P, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020; 395 (10234): 1417-1418. DOI: 10.1016/S0140-6736(20)30937-5
27. Connors JM, Levy JH. COVID-19 and its implications for thrombosis and anticoagulation. Blood. 2020; 135 (23): 2033–2040. DOI: 10.1182/blood.2020006000.
28. Barrett TJ, Bilaloglu S, Cornweel M, et al. Platelets contribute to disease severity in COVID-19. J Thromb Haemost. 2021; 19 (12): 3139-3153. DOI: 10.1111/jth.15534.
29. Fogarty H, Townsend L, Morrin H, et al. Persistent endotheliopathy in the pathogenesis of long COVID syndrome. J Thromb Haemost. 2021; 19 (10): 2546-2553. DOI: 10.1111/jth.15490.
30. Munker D, Osterman A, Stubbe H, et al. Dynamics of SARS-CoV-2 shedding in the respiratory tract depends on the severity of disease in COVID-19 patients. Eur Respir J. 2021; 58 (1): 2002724. DOI: 10.1183/13993003.02724-2020.
31. Carfi A, Bernabei R, et al. Persistent Symptoms in Patients After Acute COVID-19. JAMA. 2020; 324 (6): 603-605. DOI: 10.1001/jama.2020.12603.
32. Zheng X, Chen J, Deng L, et al. Risk factors for the COVID-19 severity and its correlation with viral shedding: A retrospective cohort study. J Med Virol. 2021; 93 (2): 952-961. DOI: 10.1002/jmv.26367.
33. Peluso MJ, Deitchman AN, Torres L, et al. Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms. Cell Rep. 2021; 36 (6): 109518. DOI: 10.1016/j.celrep.2021.109518.
34. Notarte KI, Catahay JA, Velasco J, et al. Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: A systematic review. eClin Med. 2022; 53: 101624. DOI: 10.1016/j. eclinm.2022.101624.
35. Antonelli M, Penfold RS, Merino J, et al. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: A prospective, community-based, nested, case-control study. Lancet Infect Dis. 2022; 22 (1): 43–55. DOI: 10.1016/ S1473-3099(21)00460-6.
Recommended Citation
Hutapea HM , Sudaryo MK , Parikesit AA ,
et al.
Risk Factors Associated with Long COVID Among Hospitalized Adults in Several Hospitals in Palembang City, Indonesia.
Kesmas.
2025;
20(2):
127-137
DOI: 10.7454/kesmas.v20i2.2360
Available at:
https://scholarhub.ui.ac.id/kesmas/vol20/iss2/6